You are viewing the site in preview mode
Skip to main content
|
Variable
|
Successful TB treatment (cured + completed treatment), n (%)
|
Unsuccessful TB treatment (defaulted + failed treatment + died), n (%)
|
Treatment success rate (%)
|
|---|
|
Age (year)
|
|
18–34
|
829 (46.3)
|
200 (42.5)
|
80.6
|
|
35–54
|
741 (41.4)
|
194 (41.2)
|
79.5
|
|
≥ 55
|
221 (21.3)
|
77 (16.3)
|
74.2
|
| |
χ2 = 5.612; p = 0.060
| |
|
Sex
|
|
Male
|
1028 (57.4)
|
306 (65.0)
|
77.1
|
|
Female
|
763 (42.6)
|
165 (35.0)
|
82.2
|
| |
χ2 = 8.780; p = 0.003*
| |
|
HIV status (n = 2117)
|
|
Positive
|
300 (17.8)
|
127 (29.5)
|
70.3
|
|
Negative
|
1387 (82.2)
|
303 (70.5)
|
82.1
|
| |
χ2 = 29.11; p = 0.000*
| |
|
DOTs clinic attended
|
|
UCH
|
640 (35.7)
|
219 (46.5)
|
74.5
|
|
GCHJ
|
1151 (64.3)
|
252 (53.5)
|
82.0
|
| |
χ2 = 18.215; p = 0.000*
| |
|
Year of enrolment
|
|
2013
|
325 (18.1)
|
72 (15.3)
|
81.9
|
|
2014
|
390 (21.8)
|
103 (21.9)
|
79.1
|
|
2015
|
290 (16.2)
|
75 (15.9)
|
79.5
|
|
2016
|
383 (21.4)
|
103 (21.9)
|
78.8
|
|
2017
|
403 (22.5)
|
118 (25.1)
|
77.4
|
| |
χ2 = 2.973; p = 0.562
| |
|
Overall TB treatment success rate within the 5-year period (1791 ÷ 2262)
|
79.2
|
- Treatment success rate was calculated as number of successful TB treatment divided by the sum of successful TB treatment plus unsuccessful treatment, multiply by 100. HIVHuman Immunodeficiency Virus, UCH University College Hospital, GCHJ Government Chest Hospital Jericho, DOTs Directly Observed Treatment Short-course, *Significance difference with Chi-square test, Level of statistical significance, p < 0.05, n number
